Consumer sleep technology use in individuals with obstructive sleep apnea: does it have a role in monitoring treatment response?

Consumer sleep technology (CST) has an emerging role in monitoring sleep, including screening or surveillance of sleep disorders; however, few data are available on CST in patients with obstructive sleep apnea (OSA). We analyzed attitudes towards CST and patterns of CST use among individuals with OSA. Among 251 respondents (mean age 57.5 years; 58.2% female), 66.5% reported CST use, and 92.0% indicated that monitoring OSA treatment response would be a useful feature of CST. Individuals with a household income < $30,000 (OR 0.26; p=0.008) or identifying as a minority/other race (OR 0.15; p=0.021) were less likely to use CST. Older age (beta-coefficient 0.05; p<0.001), Medicare insurance (beta-coefficient 1.26; p=0.006), and positive airway pressure use (beta-coefficient; p=0.008) were associated with increased nights/week of CST use. These findings demonstrate a high perceived value of CST for monitoring treatment response among individuals with OSA, but disparate use by sociodemographic and clinical factors.